We are live on ! Find out more
IGC icon

IGC Pharma
IGC

36 hedge funds and large institutions have $1.41M invested in IGC Pharma in 2026 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

24% more capital invested

Capital invested by funds: $1.14M → $1.41M (+$273K)

3% more funds holding

Funds holding: 35 → 36 (+1)

0.8% more ownership

Funds ownership: 4.39% → 5.19% (+0.8%)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
7
Closed
4
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$7K

Top Buyers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
+$201K
2
Citadel Advisors
Citadel Advisors
Florida
+$129K
3
Vanguard Capital Management
Vanguard Capital Management
Pennsylvania
+$28.5K
4
Jane Street
Jane Street
New York
+$18.5K
5
Northern Trust
Northern Trust
Illinois
+$16.8K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$58.3K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$48.5K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$27.7K
4
VF
Virtu Financial
New York
-$6K
5
TC
T3 Companies
New York
-$5.26K

IGC Hedge Fund Activity: Q2 2026 in Review

36 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q2 2026, worth a combined $1.41M — up 24% from $1.14M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new IGC positions and 4 closed out — a net gain of 3 holders — while 6 added to existing stakes and 7 trimmed.

The largest buyer was AdvisorShares Investments, opening a new position worth an estimated $201K. The largest seller was Renaissance Technologies, cutting an estimated $58.3K.

  • 36 institutional investors held IGC Pharma (IGC) as of Q2 2026, up from 35 in Q1 2026.
  • Funds reported $1.41M of IGC Pharma stock for Q2 2026, up 24% quarter-over-quarter.
  • 7 funds opened new IGC Pharma positions in Q2 2026 and 4 closed out, a net change of +3 holders.
  • The largest IGC Pharma buyer in Q2 2026 was AdvisorShares Investments, an estimated $201K added.
  • The largest IGC Pharma seller in Q2 2026 was Renaissance Technologies, an estimated $58.3K sold.

Based on aggregated 13F filings for Q2 2026.